DXCM vs PUBM · P/E 63, rev $2.50B vs P/E 156, rev $78.6M
DexCom Inc (DXCM) versus Pubmatic Inc (PUBM) — a side-by-side from cached financials, not a winner call.
DexCom Inc (DXCM) is a medical devices company listed on US.
Pubmatic Inc (PUBM) is a software - application company listed on US.
Latest reported DXCM revenue for 2026-06-30 was $2.50B. Net income was $448.6M. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
Latest reported PUBM revenue for 2026-06-30 was $78.6M. Net income was -$1.2M. Revenue was up 25.6% from 2026-03-31 to 2026-06-30. PUBM currently screens at market cap $604.7M and trailing P/E 155.8.
DXCM currently screens at market cap $32.84B and trailing P/E 62.5. PUBM currently screens at market cap $604.7M and trailing P/E 155.8.
Not investment advice. Open the DXCM and PUBM stock pages for the full models.
Not investment advice.